Development of a geriatric vulnerability score (GVS) in elderly advanced ovarian cancer (AOC) patients (pts) treated in first line: A prospective GINECO trial. This is an ASCO Meeting Abstract from ...
AD was present in 44.5% (251/563). EO-C-AD was present in 26.2% of AD (66/251). In the AD sample, univariate logistic regression of EO-C-AD vs BP-II, index age, female gender, recurrences, axis I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback